The EU regulations (Regulations 2017/745 on medical devices (the MDR) and 2017/746 on in vitro diagnostic medical devices (the IVDR)), introduced a prohibition of misleading advertising of medical devices.
Gessel and Wolf Theiss Advise on EMSA Capital Exit from Famed Zywiec
Gessel has advised private equity fund EMSA Capital on the full sale of Famed Zywiec to Czech fund BHM Group. Wolf Theiss advised the buyer.
B2RLaw and LSW Advise on DocPlanner's Acquisition of MyDr
B2RLaw has advised DocPlanner on its acquisition of MyDr. LSW Lesnodorski Slusarek & Partners advised the sellers.
Kinstellar, BDV, and Kramaric & Partners Advise on Adria Dental Group Financing and Acquisition of Fiziodent Polyclinic
Kinstellar Croatian affiliate Zuric i Partneri has advised OTP Banka on the financing for Adria Dental Group’s acquisition of the Fiziodent Polyclinic. Batarelo Dvojkovic Vuchetich advised the Adria Dental Group on the acquisition and financing. Kramaric & Partners advised Karlo Sudarevic on the sale.
Who May Be Subject to Advertising Regulations in Poland?
As a rule, medical device advertising can be conducted by economic operators, i.e. manufacturers, distributors, authorized representatives and importers (Article 56 (1) of the Polish Medical Devices Act of 7 April 2022 (the MDA)). Other entities can conduct advertising only after approval of the advertisement in writing by the economic operators.
Vukmir & Associates and Fatur Menard Advise Deimos Group on Acquisition of Palco and Nutrifit
Vukmir & Associates and Fatur Menard have advised the Deimos Group on the acquisition of Croatian companies Nutrifit and Palco and their Palco and Nutrifit joint venture in Slovenia. Brescia Miccoli e Associati reportedly advised the Deimos Group as well.
NKO Partners and Stanivuk & Manasijevski Advise on Dr. Max Group's Acquisition of AU Medis Lek
NKO Partners has advised the Dr. Max Group on its acquisition of the AU Medis Lek pharmacy chain in Serbia. Stanivuk & Manasijevski advised AU Medis Lek's shareholder on the sale.